Madrigal Pharmaceuticals, Inc.盘中异动大幅下挫5.05%

自选股智能写手04-02

北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报242.82美元/股，成交量12.0131万股，换手率0.58%，振幅2.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.74亿美元，每股收益-19.99美元，毛利-527000.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2424492190?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-02 22:08","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2424492190","market":"us","top_or_hot":-1,"title":"Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报242.82美元/股，成交量12.0131万股，换手率0.58%，振幅2.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.74亿美元，每股收益-19.99美元，毛利-527000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMadrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-02 22:08 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报242.82美元/股，成交量12.0131万股，换手率0.58%，振幅2.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.74亿美元，每股收益-19.99美元，毛利-527000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDGL","symbol_name":"Madrigal Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b","article_id":"2424492190","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220834791e7e7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2424492190","pubTimestamp":1712066913,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.81%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至22时08分，《Form 144 | Madrigal Pharmaceuticals董事拟出售1.1万股股份，价值约293.74万美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间4月1日披露的文件，$Madrigal Pharmaceuticals $董事RICHARD S LEVY拟于4月1日出售1.1万股普通股股份，总市值约293.74万美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MDGL":"Madrigal Pharmaceuticals, Inc.","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股"},"translate_title":"Madrigal Pharmaceuticals, Inc. plunged 5.05% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDGL":1},"content_text":"北京时间2024年04月02日22时08分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报242.82美元/股，成交量12.0131万股，换手率0.58%，振幅2.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.74亿美元，每股收益-19.99美元，毛利-527000.00美元，市盈率-12.21倍。机构评级方面，在所有14家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.81%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)、Humacyte Inc C/Wts 27/08/2026 (To Pur Com)涨幅较大，Aditxt, Inc.、Avalo Therapeutics, Inc.、Ibio, Inc.较为活跃，换手率分别为725.78%、26.09%、19.77%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)、Aditxt, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)，振幅分别为95.84%、56.92%、41.53%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。它着重于心血管疾病和非酒精性脂肪性肝炎（NASH）的治疗剂开发及其商业化。该公司的产品MGL-3196，是一种口服小分子针对肝脏的β选择性THR激动剂，用于治疗非酒精性脂肪性肝炎和家族性高胆固醇血症。此外，MGL-3196还通过增加脂肪代谢来降低血浆和肝脏中的甘油三酯并展现出抗糖尿病作用。消息层面，截至22时08分，《Form 144 | Madrigal Pharmaceuticals(MDGL.US)董事拟出售1.1万股股份，价值约293.74万美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会（SEC）美东时间4月1日披露的文件，Madrigal Pharmaceuticals 董事RICHARD S LEVY拟于4月1日出售1.1万股普通股股份，总市值约293.74万美元。其中，关联方必须持有证券至少六个月，卖出的股数不得超过已发行股份总数的1%。关联方在任何三个月期间出售的股票数量超过5,000股时，或总市值超5万美元时须向SEC提交该表格。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424492190"}

Madrigal Pharmaceuticals, Inc.盘中异动 大幅下挫5.05%

精彩评论

Madrigal Pharmaceuticals, Inc.盘中异动大幅下挫5.05%